Metraipolis › archive › dc_775413d68df7
Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist — Europe PMC PMID:34003116
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/34003116
- DOI
- 10.7554/elife.65777
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-04T09:06:40.168Z
- SHA-256 of the archived text
b926e01efc3b5ea8c134741003f01a04db58e0b0322e391fb3dc45e64a192d4b- Stable URL of this page
https://metraipolis.com/documento/dc_775413d68df7
How to cite
Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist — Europe PMC PMID:34003116 — Europe PMC (en), https://europepmc.org/article/MED/34003116 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_775413d68df7 (Metraipolis archive dc_775413d68df7, sha256 b926e01efc3b5ea8c134741003f01a04db58e0b0322e391fb3dc45e64a192d4b)
BibTeX
@misc{dc775413d68df7,
title = {Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist — Europe PMC PMID:34003116},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/34003116},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_775413d68df7; sha256 b926e01efc3b5ea8c134741003f01a04db58e0b0322e391fb3dc45e64a192d4b},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34003116. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Interleukin-2 is a pleiotropic cytokine that mediates both pro- and anti-inflammatory functions. Immune cells naturally differ in their sensitivity to IL-2 due to cell type and activation state-dependent expression of receptors and signaling pathway components. To probe differences in IL-2 signaling across cell types, we used structure-based design to create and profile a series of IL-2 variants with the capacity to titrate maximum signal strength in fine increments. One of these partial agonists, IL-2-REH, specifically expanded Foxp3+ regulatory T cells with reduced activity on CD8+ T cells due to cell type-intrinsic differences in IL-2 signaling. IL-2-REH elicited cell type-dependent differences in gene expression and provided mixed therapeutic results: showing benefit in the in vivo mouse dextran sulfate sodium (DSS) model of colitis, but no therapeutic efficacy in a transfer colitis model. Our findings show that cytokine partial agonists can be used to calibrate intrinsic differences in response thresholds across responding cell types to narrow pleiotropic actions, which may be generalizable to other cytokine and growth factor systems. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: eLife, 2021 (prima pubblicazione 2021-05-18). Identificativi: PMID 34003116 · PMCID PMC8131104 · DOI 10.7554/elife.65777. Parole chiave degli autori: Human; Biochemistry; Mouse; IL-2; Inflammation; immunology; Cytokine Signaling; Chemical Biology. Descrittori MeSH principali: Signal Transduction. Pagina: https://europepmc.org/article/MED/34003116 — https://doi.org/10.7554/elife.65777. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-04T08:59:05.005Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.